Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ruth Ladenstein Senior Consultant in Paediatric haematology–Oncology at OKIDS, Austria


Professor in Paediatrics and Senior Consultant in Paediatric Oncology of the St. Anna Children´s Hospital

Head of the Clinical Trials Unit S2IRP (Studies & Statistics for Integrated Research and Projects) at the Children’s Cancer Research Institute (CCRI) of the St. Kinderkrebsforschung e.V. (

Recent project related activities are the coordination of the European Reference Network in Paediatric Cancer (, the coordination of the EU funded network: ExPO-r-NeT “European Expert Paediatric Oncology Research Network for Diagnostics and Treatment” (, the EU FP7 funded Network of Excellence: “EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENCE” (ENCCA;, and the Austrian Medicine for Children Research Network OKIDS (  

Board member SIOP EUROPE (, SIOPE president period September 2009 – October 2012

Advisory board member of the SIOPEN Europe Neuroblastoma Group since May 2011 (; SIOPEN president from May 2007 – May 2011; Principle Coordinating Investigator of SIOPEN High Risk Neuroblastoma Trials since 2002. In 2009, during the SIOPEN presidency of Prof. Ladenstein, the SIOPEN Association to foster neuroblastoma research was established in Vienna. Currently, it has 274 active members in 29 countries.

Chair of the Austrian Group for Paediatric Haematology-Oncology (AGPHO member - Arbeitsgruppe für Pädiatrische Haematology-Onkologie)

Member of Oncology Advisory Board of the Ministry of Health Austria since 2013 

Agenda Sessions